Covid vaccines latest updatesOxford covid vaccineUniversity of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas.
Oxford's research was slowed by low infection rates over the summer, but the Phase III trials are now accumulating the data needed to report results as a renewed surge of the pandemic hits countries around the world.
Oxford is developing its vaccine in conjunction with the drugmaker AstraZeneca.Covaxin covid vaccineThe third phase of trial of India-made Covaxin will start from today in Haryana.
Last month, Bharat Biotech had said it had successfully completed interim analysis of Phase 1 and 2 trials and is initiating Phase 3 trials.On November 18, Vij had offered to.